VERTEX PHARMACEUTICALS EUROPE LTD has a total of 38 patent applications. It decreased the IP activity by 55.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are CLAROCHEM IRELAND LTD, SOLIPHARMA LLC and CRYSTAL PHARMACEUTICAL SUZHOU CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 7 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Hong Kong | 4 | |
#6 | Brazil | 1 | |
#7 | Hungary | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Montenegro | 1 | |
#11 | Mexico | 1 | |
#12 | Serbia | 1 | |
#13 | Singapore | 1 | |
#14 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Organic chemistry methods | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Morgan Adam J | 13 |
#2 | Braman Virginia | 8 |
#3 | Tung Roger D | 7 |
#4 | Uttamsingh Vinita | 5 |
#5 | Silverman I Robert | 4 |
#6 | Morgan Adam | 2 |
#7 | Virginia Braman | 2 |
#8 | Silverman Robert | 1 |
#9 | Silverman Robert I | 1 |
#10 | Morgan | 1 |
Publication | Filing date | Title |
---|---|---|
US2018125838A1 | Methods of treatment with deuterated cftr potentiators | |
WO2018080591A1 | Methods of treatment with deuterated cftr potentiators | |
CA3014275A1 | Deuterium-modified cftr modulators | |
EP3352758A4 | Deuterated cftr potentiators | |
SG10201913588YA | Administration of deuterated cftr potentiators | |
HUE047354T2 | Deuterated derivatives of ivacaftor |